Citation Impact

Citing Papers

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
2019
Cell therapy for autoimmune diseases
2007
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
2005
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
2006
The Treadmill of Destruction and the Environmental Impacts of Militaries 1
2012 Standout
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis
2010
Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review
2016
Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial
2006
American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
2011 Standout
Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts
2011
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
2008
Impact of physicians’ adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial
2015
Rheumatoid arthritis
2018 Standout
Consensus statement on the use of rituximab in patients with rheumatoid arthritis
2006
New therapies for treatment of rheumatoid arthritis
2007
Rheumatoid arthritis
2016 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes
2012 StandoutNobel
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis
2009
Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis
2008
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
2011 Standout
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
2009
Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
2013
Juvenile idiopathic arthritis
2007 Standout
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
2012
Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study
2006
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
2006
Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritis
2008
Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
2013
Psoriasis
2021 Standout
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
2005
The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study
2011
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
2009
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Forget personalised medicine and focus on abating disease activity
2012
Clinical management of psoriatic arthritis
2018
Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
2012
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
2008
Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states
2005
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
2015
Superior efficacy of combination therapy for rheumatoid arthritis: Fact or fiction?
2005
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator‐initiated, multicenter, randomized, double‐blind, parallel‐group, placebo‐controlled study
2006
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
2013
RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories
2008
Processing narratives of self-destructive behavior in routine medical encounters: Health promotion, disease prevention, and the discourse of health care
1993
Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis
2012
Development of quality indicators for monitoring of the disease course in rheumatoid arthritis
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
2007
Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study
2016
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
2020 StandoutNobel
Assessing remission in clinical practice
2007
Rheumatoid arthritis
2010 Standout
Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index
2012
Similar effects of disease‐modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: Meta‐analysis of 70 randomized placebo‐controlled or drug‐controlled studies, including 112 comparisons
2010
Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
2007
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
2010
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
2015
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Cost‐utility analysis of treatment strategies in patients with recent‐onset rheumatoid arthritis
2009
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example
2014
The burden of rheumatoid arthritis and access to treatment: a medical overview
2007
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
2008
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study
2014
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
The “new” military and income inequality: A cross national analysis
2011
Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin‐17A production
2010
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
The Simplified Disease Activity Index and Clinical Disease Activity Index to Monitor Patients in Standard Clinical Care
2009
Militarism and Militarization in Contemporary International Relations
1977
Plunder & Protection Inc.
2002
Cultural Humility Versus Cultural Competence: A Critical Distinction in Defining Physician Training Outcomes in Multicultural Education
1998 Standout
Border Pedagogy in the Age of Postmodernism
1988 Standout
The Overview on Effectiveness of Quality Enhancement for Enhancing Health Care and Professional Practice
2024 Standout
INDIE: THE INSTITUTIONAL POLITICS AND AESTHETICS OF A POPULAR MUSIC GENRE
1999 Standout
Adalimumab in the Treatment of Rheumatoid Arthritis
2006
Toward an Emergent Psychoanalytic Epistemology
1985
Mobilization Through Interpellation : James Bulger, Juvenile Crime and the Construction of a Moral Panic
1995 Standout
African Modes of Self-Writing
2002 Standout
The Visual Dimension in Organizing, Organization, and Organization Research: Core Ideas, Current Developments, and Promising Avenues
2013 Standout
Speculative Urbanism and the Making of the Next World City
2010 Standout
Migrant “Illegality” and Deportability in Everyday Life
2002 Standout
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Some practical implications of a social‐constructivist view of the psychoanalytic situation
1992 Standout
“illegal aliens” and “opportunity”: myth‐making in congressional testimony
1991
Implementation of Treat‐to‐Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial
2017
Visual Management Studies: Empirical and Theoretical Approaches*
2012 Standout
Multi-Dimensional Threat Perception and State Repression: An Inquiry into Why States Apply Negative Sanctions
1995 Standout
Re-examining the concept of the ‘independent’ record company: the case of Wax Trax! records
1995
Writing the World from an African Metropolis
2004 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
The Evolution of International Security Studies
2009 Standout
The Politics and Poetics of Infrastructure
2013 Standout
Disease activity measures for rheumatoid arthritis.
2008
Seeing Like an Oil Company: Space, Security, and Global Capital in Neoliberal Africa
2005
On the Worlding of African Cities
2001 Standout
Mortality in rheumatoid arthritis: 2008 update.
2009
Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis
2017
Natural Resources: Curse or Blessing?
2011 Standout
Corporate Warriors: The Rise of the Privatized Military Industry and Its Ramifications for International Security
2002
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis
2012
Postmodernism as Social Theory: Some Challenges and Problems
1988
Narrating Crisis: The Discursive Construction of the `Winter of Discontent'
1996 Standout
Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment
2016
Aesthetic Understanding of Organizational Life
1992
Ceasefire capitalism: military–private partnerships, resource concessions and military–state building in the Burma–China borderlands
2011 Standout
The 21st-Century Metropolis: New Geographies of Theory
2008 Standout
On the Idea of Emancipation in Management and Organization Studies
1992 Standout

Works of Peter Lock being referenced

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
2004
Armaments and Underdevelopment
1974
Consequences of the Transfer of Military-Oriented Technology on the Development Process
1977
Militarization, Arms Transfer and Arms Production in Peripheral Countries
1975
The Political Unconscious
1982
Military downsizing and growth in the security industry in Sub‐Saharan Africa
1998
Rankless by CCL
2026